From natural products to achiral drug prototypes: Potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs
- 26 July 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (18) , 5429-5432
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombinBioorganic & Medicinal Chemistry Letters, 2007
- P1,P3 Truncated Analogs of Oscillarin and their Inhibitory Activity against Blood Coagulation FactorsChimia, 2007
- Total Synthesis and Structural Confirmation of Chlorodysinosin AJournal of the American Chemical Society, 2006
- Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseasesJournal of Internal Medicine, 2005
- TheN-Acyloxyiminium Ion Aza-Prins Route to Octahydroindoles: Total Synthesis and Structural Confirmation of the Antithrombotic Marine Natural Product OscillarinJournal of the American Chemical Society, 2004
- Fibrin Clot Formation and Lysis: Basic MechanismsSeminars in Thrombosis and Hemostasis, 2000
- Structure of Thrombin Inhibited by Aeruginosin 298-A from a Blue-Green AlgaJournal of the American Chemical Society, 1998
- Atomic Structure of the Trypsin−Aeruginosin 98-B ComplexJournal of the American Chemical Society, 1998
- Design and synthesis of a novel class of thrombin inhibitors incorporating heterocyclic dipeptide surrogatesBioorganic & Medicinal Chemistry Letters, 1997
- Potent and Selective Thrombin Inhibitors Incorporating the Constrained Arginine Mimic l-3-Piperidyl(N-guanidino)alanine at P1Journal of Medicinal Chemistry, 1996